JP2022024034A5 - - Google Patents

Download PDF

Info

Publication number
JP2022024034A5
JP2022024034A5 JP2021183553A JP2021183553A JP2022024034A5 JP 2022024034 A5 JP2022024034 A5 JP 2022024034A5 JP 2021183553 A JP2021183553 A JP 2021183553A JP 2021183553 A JP2021183553 A JP 2021183553A JP 2022024034 A5 JP2022024034 A5 JP 2022024034A5
Authority
JP
Japan
Prior art keywords
drawings
present application
invention described
application
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021183553A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022024034A (ja
JP7652682B2 (ja
Filing date
Publication date
Priority claimed from PCT/JP2019/051570 external-priority patent/WO2020138481A1/ja
Application filed filed Critical
Publication of JP2022024034A publication Critical patent/JP2022024034A/ja
Publication of JP2022024034A5 publication Critical patent/JP2022024034A5/ja
Priority to JP2025041552A priority Critical patent/JP2025085744A/ja
Application granted granted Critical
Publication of JP7652682B2 publication Critical patent/JP7652682B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021183553A 2018-12-28 2021-11-10 ピロリジン化合物の結晶 Active JP7652682B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025041552A JP2025085744A (ja) 2018-12-28 2025-03-14 ピロリジン化合物の結晶

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2018247437 2018-12-28
JP2018247437 2018-12-28
PCT/JP2019/051570 WO2020138481A1 (ja) 2018-12-28 2019-12-27 ピロリジン化合物の結晶
JP2020562542A JP6977185B2 (ja) 2018-12-28 2019-12-27 ピロリジン化合物の結晶

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020562542A Division JP6977185B2 (ja) 2018-12-28 2019-12-27 ピロリジン化合物の結晶

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025041552A Division JP2025085744A (ja) 2018-12-28 2025-03-14 ピロリジン化合物の結晶

Publications (3)

Publication Number Publication Date
JP2022024034A JP2022024034A (ja) 2022-02-08
JP2022024034A5 true JP2022024034A5 (https=) 2023-01-10
JP7652682B2 JP7652682B2 (ja) 2025-03-27

Family

ID=71127176

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020562542A Active JP6977185B2 (ja) 2018-12-28 2019-12-27 ピロリジン化合物の結晶
JP2021183553A Active JP7652682B2 (ja) 2018-12-28 2021-11-10 ピロリジン化合物の結晶
JP2025041552A Pending JP2025085744A (ja) 2018-12-28 2025-03-14 ピロリジン化合物の結晶

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020562542A Active JP6977185B2 (ja) 2018-12-28 2019-12-27 ピロリジン化合物の結晶

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025041552A Pending JP2025085744A (ja) 2018-12-28 2025-03-14 ピロリジン化合物の結晶

Country Status (8)

Country Link
US (2) US12077524B2 (https=)
EP (3) EP4603143A3 (https=)
JP (3) JP6977185B2 (https=)
CN (3) CN120081826A (https=)
ES (1) ES2991904T3 (https=)
MA (1) MA54619A (https=)
TW (2) TWI870228B (https=)
WO (1) WO2020138481A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI882128B (zh) 2020-06-10 2025-05-01 日商田邊三菱製藥股份有限公司 紫質症之預防或治療劑
MX2022015804A (es) 2020-06-10 2023-04-05 Mitsubishi Tanabe Pharma Corp Agente profilactico o terapeutico para porfiria.
KR20230016008A (ko) 2020-06-10 2023-01-31 미쓰비시 타나베 파마 코퍼레이션 광선성 피부질환의 예방 또는 치료제
US20240228473A1 (en) * 2021-05-06 2024-07-11 Lg Chem, Ltd. Crystalline form v of melanocortin receptor agonist compound, and method for preparing same
US20240239783A1 (en) * 2021-05-06 2024-07-18 Lg Chem, Ltd. Crystal form vii of melanocortin receptor agonist compound and method for preparing same
AU2022271120A1 (en) * 2021-05-07 2023-11-09 Lg Chem, Ltd. Crystal form iv of organic acid salts of melanocortin receptor agonist compound, and preparation method thereof
CN117242063A (zh) * 2021-05-07 2023-12-15 株式会社Lg化学 黑皮质素受体激动剂化合物与香兰素的共晶及其制备方法
BR112023022334A2 (pt) * 2021-05-07 2023-12-26 Lg Chemical Ltd Formas cristalinas de sulfato do composto agonista do receptor de melanocortina, seus métodos de preparação, seus usos, e composições farmacêuticas compreendendo as mesmas
WO2023145959A1 (ja) 2022-01-31 2023-08-03 田辺三菱製薬株式会社 メラノコルチン1受容体アゴニストの新規用途
CN119654150A (zh) * 2022-08-03 2025-03-18 田边三菱制药株式会社 含有1-{2-[(3s,4r)-1-{[(3r,4r)-1-环戊基-3-氟-4-(4-甲氧基苯基)吡咯烷-3-基]羰基}-4-(甲氧基甲基)吡咯烷-3-基]-5-(三氟甲基)苯基}哌啶-4-甲酸或其药学上可接受的盐或者共晶的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1790637B1 (en) * 2004-09-13 2014-01-29 Ono Pharmaceutical Co., Ltd. Derivatives of N-4-piperidyl urea and medicaments containing them as active ingredient
EP1951286A4 (en) * 2005-10-07 2009-11-04 Waratah Pharmaceuticals Inc COMBINED USE OF INHIBITORS OF DPP-IV AND GASTRIN COMPOUNDS
SG11201609864UA (en) 2014-05-29 2016-12-29 Mitsubishi Tanabe Pharma Corp Novel pyrrolidine compound and application as melanocortin receptor agonist
JP6392297B2 (ja) 2015-11-27 2018-09-19 田辺三菱製薬株式会社 医薬組成物

Similar Documents

Publication Publication Date Title
JP2023115329A5 (https=)
JP2021184963A5 (https=)
JP2025027013A5 (https=)
JP2023171775A5 (https=)
JP2023103258A5 (https=)
JP2022184985A5 (https=)
JP2022024034A5 (https=)
JP2022028828A5 (https=)
JP2022025124A5 (https=)
JP2021185136A5 (https=)
JP2020010717A5 (https=)
JP2021500894A5 (https=)
JP2021503478A5 (https=)
JP2023145572A5 (https=)
JP2021512414A5 (https=)
JP2019142968A5 (https=)
JP2020127428A5 (https=)
JPWO2021188969A5 (https=)
JP2023181322A5 (https=)
JP2025011142A5 (https=)
JP2024045126A5 (https=)
JPWO2021022008A5 (https=)
JP2020120660A5 (https=)
JP2020079331A5 (https=)
JP2021008510A5 (https=)